Molecular analysis of successful cell line selection in transfected GS-NS0 myeloma cells

被引:27
作者
Barnes, Louise M.
Bentley, Catherine M.
Moy, Nicola
Dickson, Alan J.
机构
[1] Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England
[2] GlaxoSmithKline Inc, Res & Dev, Beckenham, Kent, England
关键词
chromosomal localisation; transfection; GS-NS0; expression system; mammalian cell culture; copy number; Northern and Southern analysis;
D O I
10.1002/bit.21119
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
The production of recombinant proteins from mammalian cells is now an essential part of biotechnology. However, despite this importance, the detailed characteristics of good producing cell lines remain largely unknown. The industrially important GS-NS0 mammalian expression system is able to produce large amounts of protein from relatively few copies of recombinant genes. This makes GS-NS0 cell lines ideal candidates to study the consequence of recombinant plasmid transfection in mammalian cells. This study investigated the molecular features of a panel of 17 randomly chosen GS-NS0 cell lines engineered to produce a recombinant antibody. The research analysed antibody production via enzyme-linked immunosorbent assay (ELISA), and investigated the molecular features of the transfectants by Northern, Southern and copy number analysis. The cell lines generated produced a range of antibody concentrations. In addition, for transfectants defined as producers of recombinant antibody there was a positive correlation between specific productivity and heavy chain mRNA expression. The use of Northern and Southern analysis allowed determination of the functional integrity of the transfected plasmid. Over 50% of the transfectants studied had molecular defects at the level of mRNA and/or cDNA. Cell lines were identified with suspected defects in the regulatory regions of transfected genes on addition to cell lines which lacked recombinant genes. Also, "false-positive" cell lines were generated which were able to overcome the GS selection pressure without producing any recombinant antibody. This article discusses these findings in relation to vector design.
引用
收藏
页码:337 / 348
页数:12
相关论文
共 36 条
[21]   Locus control regions - coming of age at a decade plus [J].
Li, QL ;
Harju, S ;
Peterson, KR .
TRENDS IN GENETICS, 1999, 15 (10) :403-408
[22]   Identification and expression of the TREX1 and TREX2 cDNA sequences encoding mammalian 3′→5′ exonucleases [J].
Mazur, DJ ;
Perrino, FW .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (28) :19655-19660
[23]   HIGH-LEVEL EXPRESSION OF THE HUMANIZED MONOCLONAL-ANTIBODY CAMPATH-1H IN CHINESE-HAMSTER OVARY CELLS [J].
PAGE, MJ ;
SYDENHAM, MA .
BIO-TECHNOLOGY, 1991, 9 (01) :64-68
[24]   Recombinant protein therapeutics - success rates, market trends and values to 2010 [J].
Pavlou, AK ;
Reichert, JM .
NATURE BIOTECHNOLOGY, 2004, 22 (12) :1513-1519
[25]  
PERRINO FW, 1994, J BIOL CHEM, V269, P16357
[26]   Loss of transcriptional activity of a transgene is accompanied by DNA methylation and histone deacetylation and is prevented by insulators [J].
Pikaart, MI ;
Recillas-Targa, F ;
Felsenfeld, G .
GENES & DEVELOPMENT, 1998, 12 (18) :2852-2862
[27]   On the optimal ratio of heavy to light chain genes for efficient recombinant antibody production by CHO cells [J].
Schlatter, S ;
Stansfield, SH ;
Dinnis, DM ;
Racher, AJ ;
Birch, JR ;
James, DC .
BIOTECHNOLOGY PROGRESS, 2005, 21 (01) :122-133
[28]   REMOVAL OF ANTI-HUMAN-IMMUNODEFICIENCY-VIRUS 2',3'-DIDEOXYNUCLEOSIDE MONOPHOSPHATES FROM DNA BY A NOVEL HUMAN CYTOSOLIC 3'-]5'-EXONUCLEASE [J].
SKALSKI, V ;
LIU, SH ;
CHENG, YC .
BIOCHEMICAL PHARMACOLOGY, 1995, 50 (06) :815-821
[29]  
SKARNES W, 1986, J BIOL CHEM, V261, P6629
[30]  
UNDERHILL MF, 2005, 19 ESACT M HARR UK 5